Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

PURPOSE: Comparing anatomic and functional efficacy and safety of primary treatment with either half-dose photodynamic therapy (PDT) or oral eplerenone, or crossover treatment in chronic central serous chorioretinopathy patients. METHODS: After the SPECTRA trial baseline visit, patients were randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feenstra, Helena M. A., van Dijk, Elon H. C., van Rijssen, Thomas J., Tsonaka, Roula, Diederen, Roselie M. H., Hoyng, Carel B., Schlingemann, Reinier O., Boon, Camiel J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988736/
https://www.ncbi.nlm.nih.gov/pubmed/36202933
http://dx.doi.org/10.1007/s00417-022-05836-x

Ejemplares similares

Ejemplares similares